Intech Biopharm Stock

Intech Biopharm PEG

The PEG Ratio (Price/Earnings-to-Growth) of Intech Biopharm (6461.TWO) as of Jul 25, 2026 is -1.69.

PEG

-1.69

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Intech Biopharm is 2026 -1.69 . PEG Ratio (Price/Earnings-to-Growth) of Intech Biopharm was 2025 0.00 . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Intech Biopharm Stock analysis

What does Intech Biopharm do? Intech Biopharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Intech Biopharm stock

PEG Ratio (Price/Earnings-to-Growth) of Intech Biopharm is -1.69 in 2026.

Access this data via the Eulerpool API

Valuation — Intech Biopharm

All Key Metrics — Intech Biopharm